NewslettersCancer Stem Cell NewsMammary Cell Newsβ-Escin Overcomes Trastuzumab Resistance in HER2-Positive Breast Cancer by Targeting Cancer Stem-Like FeaturesBy Bob - September 28, 20220212The effect of β-escin on trastuzumab-resistant and -sensitive cell lines in vitro was evaluated for apoptosis, expression of HER2 family members, and impact on CSC-like properties.[Cancer Cell International]Full Article